In this study, we report the remarkable recognition and assembly characteristics of D 3h symmetric basket 1 6À containing two adjoining and nonpolar cavities with six biocompatible GABA residues at their northern and southern termini. From the results of experimental ( 1 H NMR, fluorescence and UV-Vis spectroscopies) and computational (MM-MC/OPLS3e) investigations, we deduced that hexaanionic 1 6À captured two molecules of anticancer drug doxorubicin 2 + in water and accommodated them in its two deep cavities. The formation of stable 1
On the encapsulation and assembly of anticancer drugs in a cooperative fashion † . Furthermore, bolaamphiphilic 1
6À
32 2 2+ assembled into spherical nanoparticles (DLS, cryo-TEM and TEM) possessing 41% drug loading. The preorganization of abiotic receptor 1 6À and its complementarity to 2 + have been proposed to play a part in the positive cooperativity in which ten favorable noncovalent contacts (i.e. hydrogen bonds, salt bridges, C-H/p and p-p contacts) are formed between doxorubicin and the dual-cavity host. In the case of topotecan 3 + , however, the absence of multiple and favorable basket3drug interactions resulted in the predominant formation of a binary 1 6À 3 3 + complex (K 1 ¼ 2.12 AE 0.01 Â 10 4 M À1 ) and the negative homotopic allostery (a ( 1).
To summarize, our study lays out a roadmap for creating a family of novel, accessible and multivalent hosts capable of complexing anticancer agents in a cooperative manner. As basket3drug complexes organize into highly loaded nanoparticles, the reported soft material is amenable to the bottom-up construction of stimuli-responsive nanomedicine capable of effective scavenging and/or delivery of drugs. 17 In addition to such virtues, allosteric and chelate cooperativity 18 operating in the host-guest complexation of pharmaceuticals is expected to give rise to an amplied response so that small changes in the external signal (i.e. stimulus) trigger a large non-linear outcome. 19 The on/off mode 20 of delivery is, however, challenging to attain 21 yet a sought-aer strategy to achieve minimal release of the payload before reaching its targeted site followed by a burst in drug release.
Introduction

22
Recently, we reported about dual-cavity baskets comprising six 23 (S) alanine residues at their periphery ( Fig. 1 ) and acting in an allosteric manner 24 by trapping small molecules akin to nerve agents.
25 As these complexes assembled into vesicles, we became increasingly curious about examining the capacity of deeper dual-cavity 1 6À (Fig. 1A) 
Results and discussion
Dual-cavity 1 (Fig. 1B) was prepared from inexpensive anthracene, vinyl acetate and GABA by following a recently developed procedure (Scheme S1 †). 30 Aer basket 1 was dissolved in 10 mM phosphate buffer (PBS) at pH ¼ 7.0, its 1 H NMR spectrum showed a set of ve, somewhat broad, resonances corresponding to, on average, D 3h symmetric 1 6À (Fig. 2A) (Fig. 1A) . The phthalimide side arms are "bouncing" back and forth to alter the cavity size, 32 which is central to the induced-t mode of complexation of the rst molecule of drug, as discussed in the text below.
33
Variously concentrated solutions of 1 6À exhibited a sharp change in the UV-Vis extinction coefficient (3 300 , i.e. slopes in Fig. 2B ) of this chromophore at $0.12 mM. 21 The "segmental adherence to the Lambert-Beer law suggested that the basket transitioned from the monomeric to the aggregated state at 0.12 mM thereby depicting its critical aggregation concentration (CAC).
25b,34 Indeed, the results of dynamic light scattering measurements of 0.76 mM 1 6À (DLS, Fig. 2C ) were in line with the formation of nanosized particles, while the Tyndall effect was apparent for 0.4 mM but absent for the 0.05 mM solution of 1 6À ( Fig. 2C ). At last, cryo-TEM and TEM imaging ( Fig. 2D) revealed the formation of circa 40-50 nm spherical objects possessing uniform coloration with no distinguishable features (i.e. double layer). Accordingly, bolaamphiphilic 1 6À is likely populating the interior of the spherical aggregates with a packing mode that still needs to be elucidated.
34a
Aer an incremental addition of doxorubicin 2 + to basket 1 6À ( Fig. 2A) , there followed a broadening of 1 H NMR resonances from the host while signals corresponding to the drug's nuclei became ill dened. In particular, H A -H D signals from the doxorubicin's methoxybenzene (shown in red, Fig. 2A ) were difficult to resolve, as they were likely becoming magnetically shielded and broadening into the baseline. Alternatively, H E -H N signals from the doxorubicin's non-aromatic side (shown in blue, Fig. 2A ) were easier to identify by comparing the spectra.
From the NMR results, we hypothesized that doxorubicin 2 + formed a stable host-guest complex with 1 6À to result in the complexation dynamics occurring at an intermediate rate and/ or rapid T 2 relaxation of H A -H D protons 2 + inside the cavity(ies) of 1 6À . 35 As the magnetic environment and dynamics of H E -H N were perturbed to a lesser degree than H A -H D protons, however, these nuclei stayed away from the concave aromatic pockets of 1 6À . To further quantify the inclusion complexation,
we noted that incremental addition of basket 1 6À to 2 + (Fig. 3A) quenched the emission from doxorubicin; 36 the quenching was static, 37 since in the absence of the complex formation the emission from the drug remained steady (Fig. S7 †) . The binding 28 with a random distribution of residuals 38 and
. The method of continuous variation (UV-Vis, Fig. 3C could be accompanied by an aggregation of these bolaamphiphilic complexes so that the observed cooperativity is in part arising from the chelate (multivalent) cooperativity. 18 In support of such logic, the observed broadening of 1 H NMR signals of both 1 6À and 2 + in Fig. 2A could have, in part, resulted from their aggregation. First, DLS measurements of 1 6À 3 2 2 2+ showed the presence of circa 60-240 nm particles (Fig. 3D ) having electrokinetic (zeta) potential of z ¼ À33.6 (Fig. S9 †) and therefore moderate stability. 25b Likewise, TEM (Fig. 3E ) and cryo-TEM imaging (Fig. 3F) revealed the formation of nanoparticles whose size (circa 50 nm), shape and, perhaps, assembly mode were akin to those forming from 1 6À . As nanoparticles are composed of dual-cavity hosts (M w ¼ 1536) with each holding two molecules of doxorubicin (M w ¼ 2 Â 544 ¼ 1088), it follows that the material's loading is circa 41%, which is highly desirable 13 for nanomedicine.
1a
Encouraged by the results with DOX 2 + , we turned to examine the entrapment of another therapeutic anticancer drug, topotecan 3 + (Fig. 4) . This at molecule is in size and shape similar to doxorubicin (Fig. 1A) therefore making a good candidate for occupying the binding pockets of 1 returned numerous yet similar conformers populating the equilibrium (<1.5 kcal mol À1 , Fig. 5A ): all structures encompass drug 2 + docked within the host's top cavity and the methoxybenzene ring poised to form C-H/p (D, Fig. 5A ) and p-p stacking (E, Fig. 5A ) interactions with the surrounding aromatic box. Moreover, three GABA carboxylates from basket 1 6À form two hydrogen bonds A/B and salt bridge C with the drug. While the occupied cavity snugs the guest by reducing the average imide d N-N distance to 9.19-9.30Å (arithmetic mean of three d N-N distances in Fig. 5A ), the unoccupied (bottom) cavity responds by exing 25a,41 its phthalimide arms to d N-N ¼ 9.92-10.01Å ( Fig. 5D ; for empty 1 6À , d N-N ¼ 9.71-9.77Å). For the doubly populated 1 6À 3 2 2 2+ , the drug molecule docked in the top cavity preserves all ve noncovalent contacts A-E with the cavity 1 6À 32 2 2+ (Fig. 5B) . Doxorubicin residing in the bottom cavity, though, assumes an equivalent position to that in the top one with three GABA residues forming hydrogen bonds A and B and the salt bridge C to hold it in its place. The transition of singly 1 6À 32 + into doubly populated 1 6À 32 2 2+ (Fig. 5C ) is accompanied by the top cavity retaining its size d N-N ¼ 9.20-9.30Å and the bottom one shrinking to d N-N ¼ 9.07-9.27Å. The second binding event thus necessitates a reduction in the size of the bottom cavity while concurrently maintaining the shape of the top one (Fig. 5D) + as a function of the increasing concentrations of 1 6À was subjected to global (550-590 nm) nonlinear regression analysis using a 2 : 1 stoichiometric model (note that doxorubicin 2 + is in this experimental setup virtually acting as a host with the stoichiometry depicted as 2 : 1); the reported
represent the arithmetic mean and standard deviation from two independent measurements ( Fig. S8 †) ; a random distribution of residuals is shown in the inset. top grips onto the drug by using all three of its phthalimide arms and engaging in ve favourable non-covalent interactions (Fig. 5A) : the top cavity shrinks to hold the drug, while the bottom one expands; the hydrophobic effect is expected to contribute to this complexation as well. 42 With all three of the top cavity's sides being "tied", the bottom three phthalimides become more rigid 25a and thus more preorganized to, via favourable entropy, increase the affinity for the second drug molecule (K 2 ¼ 9 AE 1 Â 10 6 M À1 ). That is to say, the rst complexation preorganizes the host for the second one to occur with a minimal loss in entropy, and gain in enthalpy and the overall positive homotopic cooperativity. The role of the assembly of 1 6À 3 2 2 2+ has not been taken into consideration although it is more than likely that the process has an effect on the cooperativity and the mechanism by which the recognition takes place. A validation for our computational ndings comes from the results of 1 H NMR spectroscopic experiments ( Fig. 2A) . The methoxybenzene nuclei from doxorubicin 2 + sustained the greatest degree of magnetic perturbation to implicate it occupying the host's cavities as the theory suggests (Fig. 5) . The Monte-Carlo conformational sampling of 1 6À 33 + (Fig. 6 ) revealed topotecan docking in the basket's cavity by anchoring its lactone ring (Fig. 6A ) or dimethyl ammonium group in the aromatic box (Fig. 6B) . The apparent absence of additional noncovalent contacts between 3 + and 1 6À (except one hydrogen bond A in Fig. 6B ) makes this host-guest pair less complementary than the prior one. The basket is thus loosely held by topotecan to make the 1 6À 33 + complex less preorganized for binding another molecule of the drug. Moreover, a weaker complexation could also be alleged to provide insufcient driving force for overcoming the strain required in the second binding event. On another note, the results of the NMR titration (Fig. 4A) showed that protons at both termini of topotecan became , representing the arithmetic mean and standard deviation from two independent measurements ( Fig. S10 †) ; a random distribution of residuals is shown in the inset. (Right) Fluorescence spectra of 2 mM 3 + in the presence of increasing concentrations of 1 6À (l ex ¼ 420 nm; 298 K) in 10 mM PBS at pH ¼ 7.0.
magnetically shielded to, perhaps, indicate the concurrent existence of both computed poses shown in Fig. 6 .
Conclusions
We discovered an abiotic host capable of encapsulating two molecules of anticancer drug doxorubicin in a positive cooperative fashion with ternary drug-host complexes assembling into nanoparticles. The origin of the cooperativity can, in part, be traced back to extraordinary complementarity of the drug to the abiotic receptor in addition to its preorganization. That is to say, at least ten favorable noncovalent contacts are established between doxorubicin and the dual-cavity basket, resembling those found for receptors in the natural world. The basket acts as a "claw grabber" capturing drug molecules with its six "sticky carboxylate ngers" and snugging them within the adjoining aromatic cavities in an induced-t manner. In the case of topotecan, however, we posited that the paucity of favorable noncovalent contacts between the basket and the drug, i.e. lack of complementarity, played the key role in the observed complexation stoichiometry. In general, our discovery sets the stage for (a) improving our fundamental understanding of cooperativity in articial systems and (b) creating a family of novel hosts capable of complexing plane-shaped anticancer agents with high affinity and selectivity.
Holding a high drug payload (41%), 13 nanoparticles release doxorubicin at a lower pH 43 (Fig. S14 /S15 †) or in the presence of spermine 44 ( Fig. S16 †) , as signaled by the increase in uo-rescence.
36b,45 Accordingly, our aims shi to the examination of this so material for delivery 46 as well as scavenging 47 of anticancer drugs in biological and other competitive media. 22 In fact, with dual-cavity baskets amenable to screening protocols, 
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